Cargando…

Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies

BACKGROUND: De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Fumiaki, Fretts, Amanda M., Marklund, Matti, Ardisson Korat, Andres V., Yang, Wei-Sin, Lankinen, Maria, Qureshi, Waqas, Helmer, Catherine, Chen, Tzu-An, Virtanen, Jyrki K., Wong, Kerry, Bassett, Julie K., Murphy, Rachel, Tintle, Nathan, Yu, Chaoyu Ian, Brouwer, Ingeborg A., Chien, Kuo-Liong, Chen, Yun-yu, Wood, Alexis C., del Gobbo, Liana C., Djousse, Luc, Geleijnse, Johanna M., Giles, Graham G., de Goede, Janette, Gudnason, Vilmundur, Harris, William S., Hodge, Allison, Hu, Frank, Koulman, Albert, Laakso, Markku, Lind, Lars, Lin, Hung-Ju, McKnight, Barbara, Rajaobelina, Kalina, Riserus, Ulf, Robinson, Jennifer G., Samieri, Cecilia, Senn, Mackenzie, Siscovick, David S., Soedamah-Muthu, Sabita S., Sotoodehnia, Nona, Sun, Qi, Tsai, Michael Y., Tuomainen, Tomi-Pekka, Uusitupa, Matti, Wagenknecht, Lynne E., Wareham, Nick J., Wu, Jason H. Y., Micha, Renata, Lemaitre, Rozenn N., Mozaffarian, Dariush, Forouhi, Nita G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292352/
https://www.ncbi.nlm.nih.gov/pubmed/32530938
http://dx.doi.org/10.1371/journal.pmed.1003102
_version_ 1783546094645411840
author Imamura, Fumiaki
Fretts, Amanda M.
Marklund, Matti
Ardisson Korat, Andres V.
Yang, Wei-Sin
Lankinen, Maria
Qureshi, Waqas
Helmer, Catherine
Chen, Tzu-An
Virtanen, Jyrki K.
Wong, Kerry
Bassett, Julie K.
Murphy, Rachel
Tintle, Nathan
Yu, Chaoyu Ian
Brouwer, Ingeborg A.
Chien, Kuo-Liong
Chen, Yun-yu
Wood, Alexis C.
del Gobbo, Liana C.
Djousse, Luc
Geleijnse, Johanna M.
Giles, Graham G.
de Goede, Janette
Gudnason, Vilmundur
Harris, William S.
Hodge, Allison
Hu, Frank
Koulman, Albert
Laakso, Markku
Lind, Lars
Lin, Hung-Ju
McKnight, Barbara
Rajaobelina, Kalina
Riserus, Ulf
Robinson, Jennifer G.
Samieri, Cecilia
Senn, Mackenzie
Siscovick, David S.
Soedamah-Muthu, Sabita S.
Sotoodehnia, Nona
Sun, Qi
Tsai, Michael Y.
Tuomainen, Tomi-Pekka
Uusitupa, Matti
Wagenknecht, Lynne E.
Wareham, Nick J.
Wu, Jason H. Y.
Micha, Renata
Lemaitre, Rozenn N.
Mozaffarian, Dariush
Forouhi, Nita G.
author_facet Imamura, Fumiaki
Fretts, Amanda M.
Marklund, Matti
Ardisson Korat, Andres V.
Yang, Wei-Sin
Lankinen, Maria
Qureshi, Waqas
Helmer, Catherine
Chen, Tzu-An
Virtanen, Jyrki K.
Wong, Kerry
Bassett, Julie K.
Murphy, Rachel
Tintle, Nathan
Yu, Chaoyu Ian
Brouwer, Ingeborg A.
Chien, Kuo-Liong
Chen, Yun-yu
Wood, Alexis C.
del Gobbo, Liana C.
Djousse, Luc
Geleijnse, Johanna M.
Giles, Graham G.
de Goede, Janette
Gudnason, Vilmundur
Harris, William S.
Hodge, Allison
Hu, Frank
Koulman, Albert
Laakso, Markku
Lind, Lars
Lin, Hung-Ju
McKnight, Barbara
Rajaobelina, Kalina
Riserus, Ulf
Robinson, Jennifer G.
Samieri, Cecilia
Senn, Mackenzie
Siscovick, David S.
Soedamah-Muthu, Sabita S.
Sotoodehnia, Nona
Sun, Qi
Tsai, Michael Y.
Tuomainen, Tomi-Pekka
Uusitupa, Matti
Wagenknecht, Lynne E.
Wareham, Nick J.
Wu, Jason H. Y.
Micha, Renata
Lemaitre, Rozenn N.
Mozaffarian, Dariush
Forouhi, Nita G.
author_sort Imamura, Fumiaki
collection PubMed
description BACKGROUND: De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). METHODS AND FINDINGS: Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970–1973 to 2006–2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3–75.5 years; % women = 20.4%–62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-variance-weighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41–1.66; p < 0.001) for 16:0, 1.40 (1.33–1.48; p < 0.001) for 16:1n-7, 1.14 (1.05–1.22; p = 0.001) for 18:0, and 1.16 (1.07–1.25; p < 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I(2) = 51.1%–73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94–1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. CONCLUSIONS: Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D.
format Online
Article
Text
id pubmed-7292352
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72923522020-06-18 Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies Imamura, Fumiaki Fretts, Amanda M. Marklund, Matti Ardisson Korat, Andres V. Yang, Wei-Sin Lankinen, Maria Qureshi, Waqas Helmer, Catherine Chen, Tzu-An Virtanen, Jyrki K. Wong, Kerry Bassett, Julie K. Murphy, Rachel Tintle, Nathan Yu, Chaoyu Ian Brouwer, Ingeborg A. Chien, Kuo-Liong Chen, Yun-yu Wood, Alexis C. del Gobbo, Liana C. Djousse, Luc Geleijnse, Johanna M. Giles, Graham G. de Goede, Janette Gudnason, Vilmundur Harris, William S. Hodge, Allison Hu, Frank Koulman, Albert Laakso, Markku Lind, Lars Lin, Hung-Ju McKnight, Barbara Rajaobelina, Kalina Riserus, Ulf Robinson, Jennifer G. Samieri, Cecilia Senn, Mackenzie Siscovick, David S. Soedamah-Muthu, Sabita S. Sotoodehnia, Nona Sun, Qi Tsai, Michael Y. Tuomainen, Tomi-Pekka Uusitupa, Matti Wagenknecht, Lynne E. Wareham, Nick J. Wu, Jason H. Y. Micha, Renata Lemaitre, Rozenn N. Mozaffarian, Dariush Forouhi, Nita G. PLoS Med Research Article BACKGROUND: De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). METHODS AND FINDINGS: Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970–1973 to 2006–2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3–75.5 years; % women = 20.4%–62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-variance-weighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41–1.66; p < 0.001) for 16:0, 1.40 (1.33–1.48; p < 0.001) for 16:1n-7, 1.14 (1.05–1.22; p = 0.001) for 18:0, and 1.16 (1.07–1.25; p < 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I(2) = 51.1%–73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94–1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. CONCLUSIONS: Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. Public Library of Science 2020-06-12 /pmc/articles/PMC7292352/ /pubmed/32530938 http://dx.doi.org/10.1371/journal.pmed.1003102 Text en © 2020 Imamura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Imamura, Fumiaki
Fretts, Amanda M.
Marklund, Matti
Ardisson Korat, Andres V.
Yang, Wei-Sin
Lankinen, Maria
Qureshi, Waqas
Helmer, Catherine
Chen, Tzu-An
Virtanen, Jyrki K.
Wong, Kerry
Bassett, Julie K.
Murphy, Rachel
Tintle, Nathan
Yu, Chaoyu Ian
Brouwer, Ingeborg A.
Chien, Kuo-Liong
Chen, Yun-yu
Wood, Alexis C.
del Gobbo, Liana C.
Djousse, Luc
Geleijnse, Johanna M.
Giles, Graham G.
de Goede, Janette
Gudnason, Vilmundur
Harris, William S.
Hodge, Allison
Hu, Frank
Koulman, Albert
Laakso, Markku
Lind, Lars
Lin, Hung-Ju
McKnight, Barbara
Rajaobelina, Kalina
Riserus, Ulf
Robinson, Jennifer G.
Samieri, Cecilia
Senn, Mackenzie
Siscovick, David S.
Soedamah-Muthu, Sabita S.
Sotoodehnia, Nona
Sun, Qi
Tsai, Michael Y.
Tuomainen, Tomi-Pekka
Uusitupa, Matti
Wagenknecht, Lynne E.
Wareham, Nick J.
Wu, Jason H. Y.
Micha, Renata
Lemaitre, Rozenn N.
Mozaffarian, Dariush
Forouhi, Nita G.
Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
title Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
title_full Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
title_fullStr Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
title_full_unstemmed Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
title_short Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
title_sort fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292352/
https://www.ncbi.nlm.nih.gov/pubmed/32530938
http://dx.doi.org/10.1371/journal.pmed.1003102
work_keys_str_mv AT imamurafumiaki fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT frettsamandam fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT marklundmatti fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT ardissonkoratandresv fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT yangweisin fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT lankinenmaria fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT qureshiwaqas fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT helmercatherine fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT chentzuan fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT virtanenjyrkik fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT wongkerry fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT bassettjuliek fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT murphyrachel fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT tintlenathan fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT yuchaoyuian fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT brouweringeborga fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT chienkuoliong fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT chenyunyu fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT woodalexisc fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT delgobbolianac fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT djousseluc fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT geleijnsejohannam fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT gilesgrahamg fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT degoedejanette fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT gudnasonvilmundur fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT harriswilliams fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT hodgeallison fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT hufrank fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT koulmanalbert fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT laaksomarkku fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT lindlars fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT linhungju fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT mcknightbarbara fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT rajaobelinakalina fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT riserusulf fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT robinsonjenniferg fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT samiericecilia fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT sennmackenzie fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT siscovickdavids fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT soedamahmuthusabitas fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT sotoodehnianona fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT sunqi fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT tsaimichaely fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT tuomainentomipekka fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT uusitupamatti fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT wagenknechtlynnee fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT warehamnickj fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT wujasonhy fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT micharenata fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT lemaitrerozennn fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT mozaffariandariush fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies
AT forouhinitag fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies